Schmitz F - Search Results

1

Protective cancer immunotherapy: what can the innate immune system contribute?

Schmitz F, Heit A. Schmitz F, et al. Expert Opin Biol Ther. 2008 Jan;8(1):31-43. doi: 10.1517/14712598.8.1.31. Expert Opin Biol Ther. 2008. PMID: 18081535 Review.

2

Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.

Schmitz F, Heit A, Dreher S, Eisenächer K, Mages J, Haas T, Krug A, Janssen KP, Kirschning CJ, Wagner H. Schmitz F, et al. Eur J Immunol. 2008 Nov;38(11):2981-92. doi: 10.1002/eji.200838761. Eur J Immunol. 2008. PMID: 18924132

3

Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.

Heit A, Gebhardt F, Lahl K, Neuenhahn M, Schmitz F, Anderl F, Wagner H, Sparwasser T, Busch DH, Kastenmüller K. Heit A, et al. Among authors: schmitz f. Eur J Immunol. 2008 Jun;38(6):1585-97. doi: 10.1002/eji.200737966. Eur J Immunol. 2008. PMID: 18465771

4

Vaccine protocols for enhanced immunogenicity of exogenous antigens.

Heit A, Busch DH, Wagner H, Schmitz F. Heit A, et al. Among authors: schmitz f. Int J Med Microbiol. 2008 Jan;298(1-2):27-32. doi: 10.1016/j.ijmm.2007.08.004. Epub 2007 Sep 20. Int J Med Microbiol. 2008. PMID: 17888726 Review.

5

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.

Heit A, Schmitz F, Haas T, Busch DH, Wagner H. Heit A, et al. Among authors: schmitz f. Eur J Immunol. 2007 Aug;37(8):2063-74. doi: 10.1002/eji.200737169. Eur J Immunol. 2007. PMID: 17628858

6

Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.

Schmitz F, Heit A, Guggemoos S, Krug A, Mages J, Schiemann M, Adler H, Drexler I, Haas T, Lang R, Wagner H. Schmitz F, et al. Eur J Immunol. 2007 Feb;37(2):315-27. doi: 10.1002/eji.200636767. Eur J Immunol. 2007. PMID: 17273999

7

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines.

Heit A, Schmitz F, O'Keeffe M, Staib C, Busch DH, Wagner H, Huster KM. Heit A, et al. Among authors: schmitz f. J Immunol. 2005 Apr 1;174(7):4373-80. doi: 10.4049/jimmunol.174.7.4373. J Immunol. 2005. PMID: 15778402

8

Targeting split vaccines to the endosome improves vaccination.

Wagner H, Heit A, Schmitz F, Bauer S. Wagner H, et al. Among authors: schmitz f. Curr Opin Biotechnol. 2004 Dec;15(6):538-42. doi: 10.1016/j.copbio.2004.09.006. Curr Opin Biotechnol. 2004. PMID: 15560980 Review.

9

Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.

Schmitz F, Mages J, Heit A, Lang R, Wagner H. Schmitz F, et al. Eur J Immunol. 2004 Oct;34(10):2863-73. doi: 10.1002/eji.200425228. Eur J Immunol. 2004. PMID: 15368303

10

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.

Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J, Krug A. Steinberg C, et al. Among authors: schmitz f. Eur J Immunol. 2009 Apr;39(4):1007-18. doi: 10.1002/eji.200838814. Eur J Immunol. 2009. PMID: 19283778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results